Pediatric Targeted Therapy denied as not medically necessary by Blue Cross Blue Shield?

Blue Cross Blue Shield's specific coverage criteria for pediatric targeted therapy are defined in its own published medical/coverage policy and the FDA-approved prescribing label. A successful appeal documents that your medical records satisfy each criterion those sources list — confirmed diagnosis, any required prior treatments (with dates and outcomes), and clinical severity. If the exact criteria weren't included with your denial, request them in writing; your appeal then maps each requirement to the matching fact in your chart.

## Why BCBS Denied This Claim — and Why You Can Appeal

BCBS's medical-necessity denial for a pediatric targeted therapy means a BCBS reviewer concluded that the prescribed treatment does not meet the plan's clinical criteria for coverage — typically that it is not the most appropriate or cost-effective treatment available, or that sufficient documentation was not provided to support the clinical decision. Medical-necessity denials in pediatric targeted therapy are highly fact-specific: the treating pediatric specialist knows the child's case in a way a plan reviewer often does not. These denials are frequently reversed when the appeal presents a complete, well-organized clinical picture tied directly to BCBS's own stated coverage criteria.

## Your Federal Appeal Rights

• Internal appeal (ERISA §503 / ACA §2719): Submit a written appeal within the deadline stated on the denial notice. BCBS must assign a reviewer with relevant clinical expertise — for pediatric specialty therapy, you may explicitly request a reviewer board-certified in the relevant pediatric subspecialty.
• External review (ACA §2719): After final internal denial, you have approximately four months to file with an independent review organization. IROs apply accepted medical and scientific evidence, not the insurer's internal criteria alone.
• Expedited option: Serious pediatric illness almost always qualifies for expedited review (typically 72-hour turnaround). Request this in writing whenever delay poses a clinical risk.

## Documentation to Gather

1. Diagnosis confirmation — pathology reports, imaging, genetic or molecular testing results, and specialist evaluation establishing the diagnosis and its severity. 2. Clinical severity documentation — chart notes showing disease stage, functional status, and any prior progression or complications relevant to urgency. 3. Prior treatment history — a complete list of treatments already tried, with start and end dates, doses (from chart), and documented outcomes or reasons for change. 4. Prescriber's medical-necessity letter — the treating pediatric specialist should address each criterion in BCBS's medical necessity definition, linking each requirement to specific chart facts. This is the single most important document in the appeal. 5. Applicable guideline reference — the prescriber should cite the relevant guideline organization (e.g., COG, NCCN Pediatric, or the relevant subspecialty society) to contextualize the treatment recommendation without relying on unsupported assertions. 6. Peer-reviewed literature — published studies supporting the treatment approach for this specific diagnosis and patient population (attach as exhibits).

## Criteria-Mapping Structure for Your Appeal Letter

| BCBS medical-necessity criterion | Chart documentation addressing it | |---|---| | Diagnosis confirmed and documented | Pathology / molecular report [date] | | Standard alternatives tried or not appropriate | Prior-treatment history with outcomes | | Expected benefit documented | Prescriber's letter linking therapy to clinical goal | | Consistent with accepted medical standards | Guideline organization + published literature |

Request a copy of BCBS's clinical criteria for this drug or drug class before submitting the appeal, so your letter addresses each criterion explicitly.